FindTrial
Sign In

Clinical Characteristics and Treatment Outcomes of Segmental Infantile Hemangiomas

Clinical Features and Treatment Outcomes of Segmental Infantile Hemangioma: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128786
Enrollment
Unknown
Registered
2026-07-26
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile hemangioma (IH)

Interventions

Segmental Infantile Hemangiomas (Observational Cohort):None

Sponsors

Shanghai Ninth Peoples Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1.Infants aged within 1 year (including 1 year of age), regardless of sex; 2.Definite diagnosis of segmental infantile hemangioma based on medical history, clinical manifestations, and imaging findings (ultrasound, CT, or MRI); 3.The guardians of the infants have been informed of the study details, have signed the informed consent form, and are willing to comply with the study requirements;

Exclusion criteria

Exclusion criteria: 1.The infant's demographic information, birth history, or history of hemangioma are not detailed or clear; 2.The investigator considers that the infant is not suitable for participation in this study;

Design outcomes

Primary

MeasureTime frame
Changes in hemangioma size;—

Secondary

MeasureTime frame
Adverse events;Baseline information and treatment protocol;—

Countries

China

Contacts

Public ContactYajing Qiu

Shanghai Ninth Peoples Hospital,Shanghai Jiao Tong University School of Medicine

hedwig_qiu@live.cn+86 21 23271699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026